top of page
In this horizontal test we accurately generate all CDRs from scratch for 310 different Antibodies, including 60 approved therapeutic Antibodies.
Our Classifier module has a 95% success ratio predicting if an antibody binds a specific epitope for 310 different known antibodies.
We improve the binding affinity of an antibody targeting HER2, using Trastuzumab as starting point.
Our Use Cases
Discover the diverse and practical applications of our platform, showcasing how it can be leveraged to address and enhance operations across different scenarios.
bottom of page